Last reviewed · How we verify
Chemotherapy-induced neutropenia
Approved treatments
- Neupogen · University of Chicago
- Leukine · Berlex Labs
Leukine works by binding to the granulocyte macrophage colony-stimulating factor receptor, stimulating the production of white blood cells. - Neulasta · Amgen
Colony-stimulating factor binding hematopoietic cell surface receptors to stimulate proliferation and differentiation. - Leukine · University of Kentucky
- FULPHILA · MYLAN GMBH
- Lonquex · Sicor Biotech UAB
- Neulasta · Amgen
Neulasta stimulates the production of white blood cells by binding to their receptors. - Neupogen · Amgen
Filgrastim-aafi binds G-CSF receptors on hematopoietic cells, stimulating neutrophil proliferation, differentiation, and functional activation. - Neulasta · Columbia University
Clinical guidelines
- FDA label — adjuvant
Decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a significant incidence of severe neutropenia with fever. - FDA label — any
NYVEPRIA is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chemotherapy-induced neutropenia patent landscape — cliff calendar, originator estates, attackable patents
- Chemotherapy-induced neutropenia treatment landscape brief
- Chemotherapy-induced neutropenia treatment updates RSS
Frequently asked questions about Chemotherapy-induced neutropenia
What drugs treat Chemotherapy-induced neutropenia?
Tracked treatments include Neupogen, Leukine, Neulasta, FULPHILA, Lonquex.
What is the treatment for Chemotherapy-induced neutropenia?
Standard treatment for Chemotherapy-induced neutropenia includes Neupogen, Leukine, Neulasta, FULPHILA, Lonquex. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Chemotherapy-induced neutropenia?
FDA label publishes guidelines for Chemotherapy-induced neutropenia. 2 guideline references tracked.
Related
- Treatment landscape: Chemotherapy-induced neutropenia patent cliff · Chemotherapy-induced neutropenia CI report
- Treatment: Neupogen · University of Chicago
- Treatment: Leukine · Berlex Labs
- Treatment: Neulasta · Amgen
- Treatment: Leukine · University of Kentucky
- Treatment: FULPHILA · MYLAN GMBH
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing